← Open Payments lookup

MARGARET RINCKHOFF: Open Payments

NPI 1093108821 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,924 in 105 payments from 15 companies in 2025. Trend: 2023 $1,121 · 2024 $1,372 · 2025 $1,924

Food & beverage: $1,924
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$332
Alkermes, Inc.13$284
Vanda Pharmaceuticals Inc.12$228
Janssen Pharmaceuticals, Inc12$211
Teva Pharmaceuticals USA, Inc.11$177
Otsuka America Pharmaceutical, Inc.9$165
E.R. Squibb & Sons, L.L.C.9$144
Luye Pharma (USA) Ltd.6$111
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$79
Lundbeck LLC4$74

Products named: INGREZZA, ARISTADA, INVEGA SUSTENNA, FANAPT, REXULTI, COBENFY, ERZOFRI EXTENDED-RELEASE, UZEDY.

Industry payments across NJ — which companies pay providers there.